Quest Diagnostics

Quest Diagnostics

Price: 203.78

Company and Business Model

Quest Diagnostics is a leading provider of diagnostic information services, primarily focused on laboratory testing and related services. Its core products include clinical laboratory tests, anatomic pathology services, and genetic testing. The company operates through various segments, including Diagnostic Information Services and Diagnostic Solutions, with major revenue sources stemming from patient testing, healthcare provider services, and employer services. Quest Diagnostics serves a diverse clientele, including hospitals, physicians, and patients.

Investment Profile

The investment profile of Quest Diagnostics is more aligned with dividend investors due to its consistent dividend yield of 2.0%. The company demonstrates stable revenue streams, although recent quarterly revenue showed a slight decline. This stability may appeal to those seeking income rather than aggressive growth. The stock may also attract value investors looking for established companies with reliable earnings.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
9.17 OK
Revenue QoQ — quarter-over-quarter revenue growth
3.2%
EPS surprise
3.0% in line
20d volatility
1.3% stable
Dividend yield
2.0% moderate last ex-date: 2026-04-06
FMP / FinFeed data updated: 2026-06-11
Reco: Buy Potential: 73 Risk: 32 Updated: 2026-06-11 05:37
How recommendation works
Why AI thinks so:
Strong fundamentals and positive momentum support growth outlook.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-05-30 02:36 Hold Buy Stable earnings but mixed momentum signals present uncertainty.
2026-05-08 15:18 Hold Weak momentum and fundamentals suggest caution.
2026-05-07 03:06 Hold Buy Компания показывает стабильные финансовые показатели, однако недавнее снижение цен акций и отрицательная динамика выручки могут указывать на неопределенность в краткосрочной перспективе.
Analyst forecasts
Date Analyst Action Target Price Then
2026-04-21 18:51 Evercore ISI Target Raised 210 → 225 205.18
2026-04-21 18:00 Jefferies Target Raised 220 → 225 205.18
2026-04-08 13:09 Evercore ISI Update — → 210 198.81

Nothing yet